BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22802007)

  • 1. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
    Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
    Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
    Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors.
    Yellin A; Zwas ST; Rozenman J; Simansky DA; Goshen E
    Isr Med Assoc J; 2005 Nov; 7(11):712-6. PubMed ID: 16308994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids.
    Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R
    Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    Eur J Cardiothorac Surg; 2017 May; 51(5):874-879. PubMed ID: 28204100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
    Lococo F; Perotti G; Cardillo G; De Waure C; Filice A; Graziano P; Rossi G; Sgarbi G; Stefanelli A; Giordano A; Granone P; Rindi G; Versari A; Rufini V
    Clin Nucl Med; 2015 Mar; 40(3):e183-9. PubMed ID: 25608152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
    Belhocine T; Foidart J; Rigo P; Najjar F; Thiry A; Quatresooz P; Hustinx R
    Nucl Med Commun; 2002 Aug; 23(8):727-34. PubMed ID: 12124477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic imaging of typical lung carcinoids: relationship between MDCT,
    Danti G; Berti V; Abenavoli E; Briganti V; Linguanti F; Mungai F; Pradella S; Miele V
    Radiol Med; 2020 Aug; 125(8):715-729. PubMed ID: 32189174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
    Koopmans KP; de Vries EG; Kema IP; Elsinga PH; Neels OC; Sluiter WJ; van der Horst-Schrivers AN; Jager PL
    Lancet Oncol; 2006 Sep; 7(9):728-34. PubMed ID: 16945767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
    Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
    Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U
    J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.
    Abgral R; Leboulleux S; Déandreis D; Aupérin A; Lumbroso J; Dromain C; Duvillard P; Elias D; de Baere T; Guigay J; Ducreux M; Schlumberger M; Baudin E
    J Clin Endocrinol Metab; 2011 Mar; 96(3):665-71. PubMed ID: 21193541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
    Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
    Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
    Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
    Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.